FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077074 [Registered on: 20/11/2024] Trial Registered Prospectively
Last Modified On: 18/11/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Other 
Public Title of Study   Assessing the Impact of Combined TENS and Myofascial Release Therapy for Young Women with Cervicogenic Headaches: A Pilot Study 
Scientific Title of Study   Evaluating the Efficacy of Transcutaneous Electrical Nerve Stimulation and Myofascial Release among Young Females with Cervicogenic Headache- A pilot feasibility trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sumera Khan 
Designation  Associate Professor 
Affiliation  galgotias university 
Address  room no- E004 Department of Physiotherapy,School of Allied Health Science, Galgotias University,Opposite Buddha International Circuit Gautam Buddha Nagar UTTAR PRADESH 203201 India

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  917827777195  
Fax    
Email  Sumera.khan@galgotiasuniversity.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sumera Khan 
Designation  Associate Professor 
Affiliation  galgotias university 
Address  room no- E004 Department of Physiotherapy,School of Allied Health Science, Galgotias University,Opposite Buddha International Circuit Gautam Buddha Nagar UTTAR PRADESH 203201 India

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  917827777195  
Fax    
Email  Sumera.khan@galgotiasuniversity.edu.in  
 
Details of Contact Person
Public Query
 
Name  Soni Singh 
Designation  Student 
Affiliation  Galgotias University 
Address  room no- E004 Department of Physiotherapy,School of Allied Health Science, Galgotias University,Opposite Buddha International Circuit Gautam Buddha Nagar UTTAR PRADESH 203201 India

Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  916397504466  
Fax    
Email  physiotherapistsonisingh@gmail.com  
 
Source of Monetary or Material Support  
Galgotias University, Opposite Buddha International Circuit Gautam Buddha Nagar, Uttar Pradesh Gautam Buddha Nagar UTTAR PRADESH 203201 India 
 
Primary Sponsor  
Name  Galgotias University 
Address  Galgotias University, Opposite Buddha International Circuit Gautam Buddha Nagar, Uttar Pradesh Gautam Buddha Nagar UTTAR PRADESH 203201 India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sumera Khan  Galgotias University  Room no E004, Department of Physiotherapy, School of Allied Sciences , Galgotias University, Plot no 2 , sector 17A , Opposite Buddh International Circuit, GreaterNoida , G.B Nagar, Uttar Pradesh, India 203201
Gautam Buddha Nagar
UTTAR PRADESH 
7827777195

sumera.khan@galgotiasuniversity.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
departmental research committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G448||Other specified headache syndromes,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  TENS  or TENS treatment of cervicogenic headaches in females, adhesive electrodes are placed on the cervical and upper back muscles. A low-frequency current is applied for 20-30 minutes per session to reduce pain and stimulate endorphin release. 
Intervention  TENS with MFR  Myofascial Release (MFR): MFR will be applied to the cervical and upper back regions to release muscle tightness and fascial restrictions. The therapist will use sustained pressure on trigger points for 20-30 minutes to alleviate pain and improve mobility. Transcutaneous Electrical Nerve Stimulation (TENS): TENS will be applied using adhesive electrodes placed on the cervical and upper back muscles. A low-frequency current will be used for 20-30 minutes per session to reduce pain and enhance endorphin release. Combined Treatment Protocol: Each session will include both MFR (20-30 minutes) followed by TENS therapy (20-30 minutes) to provide both immediate pain relief and address the underlying musculoskeletal dysfunction. Frequency and Duration: The combined treatment will be given 3 times per week for 4 weeks, with each session lasting 40-60 minutes. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Gender: Only females will be included in the study.
2. Age Range: Participants aged between 20-40 years.
3. Diagnosis: Clinically diagnosed with cervicogenic headaches as per standardized diagnostic criteria.
4. Duration of Symptoms: Suffering from cervicogenic headaches for a minimum of 3 months.
5. Pain Intensity: Baseline headache intensity of moderate to severe on the visual analog scale (VAS).
6. Willingness to Participate: Participants must provide written informed consent and agree to adhere to the treatment protocol and follow-up schedule.
7. No Recent Treatment: Participants must not have received any physiotherapy, TENS, or manual therapy interventions in the last 3 months.
 
 
ExclusionCriteria 
Details  1. Other Headache Types: Exclude participants diagnosed with migraines, tension-type headaches, or any other primary headache disorders.
2. Neck or Spine Surgery: Exclusion of individuals with a history of cervical spine surgery or other surgical interventions.
3. Neurological Disorders: Those with neurological conditions like multiple sclerosis or epilepsy that could influence treatment outcomes.
4. Chronic Pain Syndromes: Exclude individuals diagnosed with fibromyalgia, rheumatoid arthritis, or other systemic musculoskeletal or autoimmune disorders.
5. Pregnancy: Pregnant women or those planning to become pregnant during the study period.
6. Pacemaker or Electrical Implants: Exclude participants with pacemakers or other implanted electrical devices that could interfere with TENS therapy.
7. Psychiatric Conditions: Severe psychiatric disorders (e.g., major depressive disorder, schizophrenia) that might impact the perception of pain or adherence to treatment protocols.
8. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Pain Intensity (VAS): Measure reduction in pain severity using the Visual Analog Scale (VAS).
Headache Frequency: Track the number of headache episodes per week.
Cervical Range of Motion (ROM): Assess improvements in neck mobility.
Patient Global Impression of Change (PGIC): Evaluate overall patient-reported improvement after treatment. 
at baseline 
 
Secondary Outcome  
Outcome  TimePoints 
Neck Disability Index (NDI): Measure disability caused by neck pain and its impact on daily activities.
Quality of Life (SF-36 or EQ-5D): Assess changes in overall physical, emotional, and social well-being.
Muscle Tension: Evaluate reduction in muscle tightness through palpation.
Psychological Impact (DASS or STAI): Measure changes in anxiety, stress, and depression levels. 
at baseline 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This pilot feasibility trial investigates the effectiveness of a combination therapy using Transcutaneous Electrical Nerve Stimulation (TENS) and Myofascial Release (MFR) in young females with cervicogenic headache (CGH). CGH, a secondary headache originating from the cervical spine, can result in chronic discomfort, limited neck mobility, and reduced quality of life. While TENS is commonly used for pain relief by delivering low-voltage electrical currents to stimulate nerves, MFR is a manual technique aimed at releasing muscle tightness and improving tissue flexibility. Both therapies are non-invasive and are widely used for pain management, but limited research has examined the synergistic effects of using them together.

The primary objective of this study is to assess the feasibility, safety, and initial therapeutic outcomes of combining TENS and MFR in managing CGH. Outcome measures include the frequency, intensity, and duration of headaches, as well as functional capacity and overall quality of life. By evaluating participant adherence, tolerance, and any adverse effects, this study will determine the practicality of conducting a larger randomized controlled trial on this combination therapy.

Preliminary findings could reveal whether TENS and MFR offer complementary effects that enhance pain management, allowing young females with CGH to experience improved physical function and daily comfort. This research contributes to expanding non-pharmacological treatment options for CGH, emphasizing personalized and accessible interventions. If successful, the study could pave the way for more comprehensive approaches in treating CGH, providing an evidence base for integrating TENS and MFR into clinical practice for this demographic.
 
Close